Rapacuronium Medication Information

Get detailed information on Rapacuronium, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it.

The updated prescription information on Rapacuronium provides an overview of possible side effects, precautions, warnings, and storage tips.

You'll also find brand names used in india and internationally, along with pricing details. For further clarification, consult your healthcare provider.

Generic Name : Rapacuronium

Pronunciation : rap'a-ku-ro'ne-um

ICD Code : Y55.1 Therapeutic Classification : Antispasmodics

Trade Names/Brand Names of Rapacuronium

India :

Esmeron, Rocsur, Rocunium.

International :

Raplon

Overview of Rapacuronium

Note: Not Available in US market.

Why is Rapacuronium Prescribed? (Indications)

This medication is a neuromuscular blocker, prescribed as an adjunct to general anesthesia to facilitate tracheal intubations.

When should Rapacuronium not be taken? (Contraindications)

Hypersensitivity.

What is the dosage of Rapacuronium?

IV- The recommended initial dose is 1.5 to 2.5mg/kg.

How should Rapacuronium be taken?

It comes as a solution for injection, to be administered by a healthcare provider into the vein.

What are the warnings and precautions for Rapacuronium?

• Caution should be exercised in patients with history of kidney or liver impairment, head injury, elderly, children, during pregnancy and breastfeeding.

• Avoid long-term use of this medication.

• Patient may develop with increased risk of allergic reactions; if it so consult with your doctor.

What are the side effects of Rapacuronium?

Body as a Whole- Low blood pressure, fast/slow heart rate, fever, rigors, back pain, chills, chest pain, swelling in the leg and pain.
Heart- High blood pressure, abnormal ECG, abnormal heart rhythm and stroke.
Gastrointestinal- Vomiting, nausea, bowel obstruction and increased saliva.
Blood- Blood clot events and post-operative bleeding.
Musculoskeletal- Muscle pain.
Central Nervous System- Decreased sensitivity, weakness, tightness of muscle, prolonged neuromuscular block and prolonged anesthesia emergence.
Respiratory- Asthma, poor oxygen supply, increased airway pressure, cough, shortness of breath, respiratory depression and upper airway obstruction.
Skin- Rash, injection site pain, hives, itching and increased sweating.
Eye and ENT- Eye inflammation, miosis (constriction of eye pupil) and decreased hearing.
Genitourinary- Urinary retention and decreased urination.